10-Q Filing

CDT EQUITY INC. CIK: 1896212 Q3 2024

Filing Information

Form Type	10-Q
Accession Number	`0001493152-24-046088`
Period End Date	20240930
Filing Date	20241114
Fiscal Year	2024
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 120 Cash Flow Statement 228 Stockholders Equity 92

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$18.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$18.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	73.83M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	73.83M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	96.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	96.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.00M	shares	Point-in-time
Marketable Investments	`MarketableSecurities`	$81.00K	USD	Point-in-time
Marketable Investments	`MarketableSecurities`	$81.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	73.83M	shares	Point-in-time
Marketable Investments	`MarketableSecurities`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	96.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	96.00M	shares	Point-in-time
Marketable Investments	`MarketableSecurities`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	73.83M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.25M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.25M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.50M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.50M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.73M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.73M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.40M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$292.00K	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$292.00K	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$48.00K	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$48.00K	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$1.26M	USD	Point-in-time
Prepaid expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$1.26M	USD	Point-in-time
Prepaid expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$1.49M	USD	Point-in-time
Prepaid expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$1.49M	USD	Point-in-time
Total assets	`Assets`	$2.99M	USD	Point-in-time
Total assets	`Assets`	$2.99M	USD	Point-in-time
Total assets	`Assets`	$7.22M	USD	Point-in-time
Total assets	`Assets`	$7.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$215.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$215.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherAccruedLiabilitiesCurrent`	$601.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherAccruedLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherAccruedLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherAccruedLiabilitiesCurrent`	$601.00K	USD	Point-in-time
Bank overdraft	`BankOverdrafts`	$118.00K	USD	Point-in-time
Bank overdraft	`BankOverdrafts`	$118.00K	USD	Point-in-time
Bank overdraft	`BankOverdrafts`	-	USD	Point-in-time
Bank overdraft	`BankOverdrafts`	-	USD	Point-in-time
Convertible promissory note payable	`ConvertibleNotesPayable`	$800.00K	USD	Point-in-time
Convertible promissory note payable	`ConvertibleNotesPayable`	$800.00K	USD	Point-in-time
Convertible promissory note payable	`ConvertibleNotesPayable`	$800.00K	USD	Point-in-time
Convertible promissory note payable	`ConvertibleNotesPayable`	$800.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$147.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$147.00K	USD	Point-in-time
Loans payable	`LoansPayableCurrent`	$185.00K	USD	Point-in-time
Loans payable	`LoansPayableCurrent`	$185.00K	USD	Point-in-time
Loans payable	`LoansPayableCurrent`	$1.49M	USD	Point-in-time
Loans payable	`LoansPayableCurrent`	$1.49M	USD	Point-in-time
Deferred commission payable	`DeferredCompensationLiabilityCurrent`	$5.74M	USD	Point-in-time
Deferred commission payable	`DeferredCompensationLiabilityCurrent`	$5.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.98M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.98M	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	$142.00K	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	$142.00K	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	$24.00K	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	$24.00K	USD	Point-in-time
Operating lease liability, non-current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability, non-current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$110.00K	USD	Point-in-time
Operating lease liability, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$110.00K	USD	Point-in-time
Deferred commission payable	`DeferredCompensationLiabilityClassifiedNoncurrent`	-	USD	Point-in-time
Deferred commission payable	`DeferredCompensationLiabilityClassifiedNoncurrent`	-	USD	Point-in-time
Deferred commission payable	`DeferredCompensationLiabilityClassifiedNoncurrent`	$5.74M	USD	Point-in-time
Deferred commission payable	`DeferredCompensationLiabilityClassifiedNoncurrent`	$5.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.11M	USD	Point-in-time
Commitments and contingencies (see note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively, 96,004,699 and 73,829,536 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively, 96,004,699 and 73,829,536 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively, 96,004,699 and 73,829,536 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively, 96,004,699 and 73,829,536 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$17.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$17.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.82M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.82M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.42M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-26.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-26.70M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$411.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$411.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$271.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$271.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-5.46M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-5.46M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-14.14M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-9.12M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-9.12M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-14.14M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$7.22M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$2.99M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$7.22M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$2.99M	USD	Point-in-time

Income Statement 120 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	-	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	-	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	-	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	-	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$3.09M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$3.09M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$3.25M	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$3.25M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.66M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.66M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.83M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.83M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$430.00K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.72M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.72M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$430.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.81M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.81M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$430.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$430.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$11.91M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$11.91M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.83M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.83M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-11.91M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-11.91M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.83M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.83M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.81M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-430.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-430.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.81M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.95M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.95M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$2.15M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$2.15M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-341.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-341.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$3.10M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$3.10M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$11.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$11.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	-	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$547.00K	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$547.00K	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$92.00K	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$92.00K	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$309.00K	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$309.00K	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$47.00K	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$47.00K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$2.05M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-3.49M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-3.49M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$2.05M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-650.00K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-650.00K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$3.06M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$3.06M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-6.46M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-6.46M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-15.40M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-15.40M	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.01	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.01	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.20	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.20	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.06	USD	3 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.06	USD	3 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.20	USD	3 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.20	USD	3 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	64.89M	shares	3 Qtrs
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	65.41M	shares	1 Quarter
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	65.41M	shares	1 Quarter
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	64.89M	shares	3 Qtrs
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	87.16M	shares	1 Quarter
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	78.31M	shares	3 Qtrs
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	78.31M	shares	3 Qtrs
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	87.16M	shares	1 Quarter
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.16M	shares	1 Quarter
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	65.49M	shares	3 Qtrs
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	65.49M	shares	3 Qtrs
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.31M	shares	3 Qtrs
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.31M	shares	3 Qtrs
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	66.13M	shares	1 Quarter
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	66.13M	shares	1 Quarter
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.16M	shares	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$610.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$610.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-116.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-116.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-140.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$36.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$36.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-140.00K	USD	3 Qtrs
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$3.23M	USD	1 Quarter
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$3.23M	USD	1 Quarter
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-744.00K	USD	3 Qtrs
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-15.54M	USD	3 Qtrs
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-6.58M	USD	1 Quarter
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-6.58M	USD	1 Quarter
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-744.00K	USD	3 Qtrs
Total comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-15.54M	USD	3 Qtrs

Cash Flow Statement 228 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.40M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-15.40M	USD	3 Qtrs
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	$1.31M	USD	3 Qtrs
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	$1.31M	USD	3 Qtrs
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	-	USD	3 Qtrs
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	-	USD	3 Qtrs
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	-	USD	3 Qtrs
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	-	USD	3 Qtrs
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	$748.00K	USD	3 Qtrs
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	$748.00K	USD	3 Qtrs
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	$1.01M	USD	3 Qtrs
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	$1.01M	USD	3 Qtrs
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	-	USD	3 Qtrs
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	-	USD	3 Qtrs
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	$240.00K	USD	3 Qtrs
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	-	USD	3 Qtrs
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	-	USD	3 Qtrs
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	$240.00K	USD	3 Qtrs
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	-	USD	3 Qtrs
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	-	USD	3 Qtrs
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	$423.00K	USD	3 Qtrs
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	$423.00K	USD	3 Qtrs
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	-	USD	3 Qtrs
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	-	USD	3 Qtrs
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	$12.00K	USD	3 Qtrs
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	$12.00K	USD	3 Qtrs
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	$38.00K	USD	3 Qtrs
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	$38.00K	USD	3 Qtrs
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	-	USD	3 Qtrs
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	-	USD	3 Qtrs
Unrealized foreign exchange loss	`UnrealizedForeignExchangeLoss`	$4.00K	USD	3 Qtrs
Unrealized foreign exchange loss	`UnrealizedForeignExchangeLoss`	$4.00K	USD	3 Qtrs
Unrealized foreign exchange loss	`UnrealizedForeignExchangeLoss`	-	USD	3 Qtrs
Unrealized foreign exchange loss	`UnrealizedForeignExchangeLoss`	-	USD	3 Qtrs
Issuance of warrants for lock-up	`AdjustmentOfWarrantsGrantedForServices`	-	USD	3 Qtrs
Issuance of warrants for lock-up	`AdjustmentOfWarrantsGrantedForServices`	-	USD	3 Qtrs
Issuance of warrants for lock-up	`AdjustmentOfWarrantsGrantedForServices`	$2.71M	USD	3 Qtrs
Issuance of warrants for lock-up	`AdjustmentOfWarrantsGrantedForServices`	$2.71M	USD	3 Qtrs
Interest expense on convertible promissory note	`InterestExpenseOnConvertiblePromissoryNote`	$86.00K	USD	3 Qtrs
Interest expense on convertible promissory note	`InterestExpenseOnConvertiblePromissoryNote`	$86.00K	USD	3 Qtrs
Interest expense on convertible promissory note	`InterestExpenseOnConvertiblePromissoryNote`	$31.00K	USD	3 Qtrs
Interest expense on convertible promissory note	`InterestExpenseOnConvertiblePromissoryNote`	$31.00K	USD	3 Qtrs
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	$1.48M	USD	3 Qtrs
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	$1.48M	USD	3 Qtrs
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	-	USD	3 Qtrs
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	-	USD	3 Qtrs
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-8.00K	USD	1 Quarter
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-131.00K	USD	1 Quarter
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-131.00K	USD	1 Quarter
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-8.00K	USD	1 Quarter
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-131.00K	USD	3 Qtrs
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-131.00K	USD	3 Qtrs
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-118.00K	USD	3 Qtrs
Gain on change in fair value of derivative warrant liability	`FairValueAdjustmentOfWarrants`	$-118.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$10.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$10.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.27M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.27M	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$8.00K	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$8.00K	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$268.00K	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$268.00K	USD	3 Qtrs
Operating lease obligations	`NoncashLeaseExpense`	$-33.00K	USD	3 Qtrs
Operating lease obligations	`NoncashLeaseExpense`	$-33.00K	USD	3 Qtrs
Operating lease obligations	`NoncashLeaseExpense`	-	USD	3 Qtrs
Operating lease obligations	`NoncashLeaseExpense`	-	USD	3 Qtrs
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	$44.00K	USD	3 Qtrs
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	$44.00K	USD	3 Qtrs
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	$1.30M	USD	3 Qtrs
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	$1.30M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfDebtIssuanceCosts`	$143.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfDebtIssuanceCosts`	$143.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfDebtIssuanceCosts`	-	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfDebtIssuanceCosts`	-	USD	3 Qtrs
Depreciation Expense	`DepreciationExpense`	-	USD	3 Qtrs
Depreciation Expense	`DepreciationExpense`	-	USD	3 Qtrs
Depreciation Expense	`DepreciationExpense`	$5.00K	USD	3 Qtrs
Depreciation Expense	`DepreciationExpense`	$5.00K	USD	3 Qtrs
Issuance of common stock for services and licensing right	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Issuance of common stock for services and licensing right	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Issuance of common stock for services and licensing right	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.72M	USD	3 Qtrs
Issuance of common stock for services and licensing right	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.72M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$210.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$210.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.44M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.44M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.64M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.64M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$839.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$839.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.60M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.60M	USD	3 Qtrs
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.87M	USD	3 Qtrs
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.87M	USD	3 Qtrs
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.92M	USD	3 Qtrs
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.92M	USD	3 Qtrs
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	3 Qtrs
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	3 Qtrs
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	$357.00K	USD	3 Qtrs
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	$357.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.00K	USD	3 Qtrs
Purchases of short term investments	`PaymentsToAcquireShortTermInvestments`	$490.00K	USD	3 Qtrs
Purchases of short term investments	`PaymentsToAcquireShortTermInvestments`	$490.00K	USD	3 Qtrs
Proceeds from the sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$413.00K	USD	3 Qtrs
Proceeds from the sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$413.00K	USD	3 Qtrs
Proceeds from the issuance of options	`ProceedsFromIssuanceOfOptions`	-	USD	3 Qtrs
Proceeds from the issuance of options	`ProceedsFromIssuanceOfOptions`	-	USD	3 Qtrs
Proceeds from the issuance of options	`ProceedsFromIssuanceOfOptions`	$585.00K	USD	3 Qtrs
Proceeds from the issuance of options	`ProceedsFromIssuanceOfOptions`	$585.00K	USD	3 Qtrs
Net cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-128.00K	USD	3 Qtrs
Net cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-128.00K	USD	3 Qtrs
Net cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$228.00K	USD	3 Qtrs
Net cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$228.00K	USD	3 Qtrs
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	$8.49M	USD	3 Qtrs
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	$8.49M	USD	3 Qtrs
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	-	USD	3 Qtrs
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	-	USD	3 Qtrs
Net proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	$498.00K	USD	3 Qtrs
Net proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	$498.00K	USD	3 Qtrs
Net proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	$1.62M	USD	3 Qtrs
Net proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	$1.62M	USD	3 Qtrs
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	$151.00K	USD	3 Qtrs
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	$151.00K	USD	3 Qtrs
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	-	USD	3 Qtrs
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	-	USD	3 Qtrs
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	$1.47M	USD	3 Qtrs
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	$1.47M	USD	3 Qtrs
Interest paid on convertible promissory note, carried at cost	`InterestPaidOnConvertiblePromissoryNoteCarriedAtCost`	$81.00K	USD	3 Qtrs
Interest paid on convertible promissory note, carried at cost	`InterestPaidOnConvertiblePromissoryNoteCarriedAtCost`	$81.00K	USD	3 Qtrs
Interest paid on convertible promissory note, carried at cost	`InterestPaidOnConvertiblePromissoryNoteCarriedAtCost`	-	USD	3 Qtrs
Interest paid on convertible promissory note, carried at cost	`InterestPaidOnConvertiblePromissoryNoteCarriedAtCost`	-	USD	3 Qtrs
Proceeds from issuance of warrants from lock-up	`ProceedsFromIssuanceOfWarrants`	$114.00K	USD	3 Qtrs
Proceeds from issuance of warrants from lock-up	`ProceedsFromIssuanceOfWarrants`	$114.00K	USD	3 Qtrs
Proceeds from issuance of warrants from lock-up	`ProceedsFromIssuanceOfWarrants`	-	USD	3 Qtrs
Proceeds from issuance of warrants from lock-up	`ProceedsFromIssuanceOfWarrants`	-	USD	3 Qtrs
Bank Overdraft	`ProceedsFromBankDebt`	$118.00K	USD	3 Qtrs
Bank Overdraft	`ProceedsFromBankDebt`	$118.00K	USD	3 Qtrs
Bank Overdraft	`ProceedsFromBankDebt`	-	USD	3 Qtrs
Bank Overdraft	`ProceedsFromBankDebt`	-	USD	3 Qtrs
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	$813.00K	USD	3 Qtrs
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	$813.00K	USD	3 Qtrs
Net cash flows provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.86M	USD	3 Qtrs
Net cash flows provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.86M	USD	3 Qtrs
Net cash flows provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.34M	USD	3 Qtrs
Net cash flows provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.34M	USD	3 Qtrs
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-4.14M	USD	3 Qtrs
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-4.14M	USD	3 Qtrs
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.65M	USD	3 Qtrs
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.65M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-17.00K	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-17.00K	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-5.00K	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-5.00K	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.64M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.64M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.16M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.16M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.64M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.64M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$71.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$71.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$71.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$71.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.64M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.64M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$80.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$80.00K	USD	3 Qtrs
Right-of-use assets obtained in exchange for operating lease liabilities	`LiabilitiesAssumed1`	$350.00K	USD	3 Qtrs
Right-of-use assets obtained in exchange for operating lease liabilities	`LiabilitiesAssumed1`	$350.00K	USD	3 Qtrs
Right-of-use assets obtained in exchange for operating lease liabilities	`LiabilitiesAssumed1`	-	USD	3 Qtrs
Right-of-use assets obtained in exchange for operating lease liabilities	`LiabilitiesAssumed1`	-	USD	3 Qtrs
Receivables from issuance of warrants for lock-up	`ReceivablesFromIssuanceOfWarrantsForLockup`	$67.00K	USD	3 Qtrs
Receivables from issuance of warrants for lock-up	`ReceivablesFromIssuanceOfWarrantsForLockup`	$67.00K	USD	3 Qtrs
Receivables from issuance of warrants for lock-up	`ReceivablesFromIssuanceOfWarrantsForLockup`	-	USD	3 Qtrs
Receivables from issuance of warrants for lock-up	`ReceivablesFromIssuanceOfWarrantsForLockup`	-	USD	3 Qtrs
Receivable from issuance of note payable	`ReceivableFromIssuanceOfNotePayable`	$525.00K	USD	3 Qtrs
Receivable from issuance of note payable	`ReceivableFromIssuanceOfNotePayable`	$525.00K	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`StockIssued1`	$151.00K	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`StockIssued1`	$151.00K	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`StockIssued1`	-	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`StockIssued1`	-	USD	3 Qtrs
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConvertibleNotesForSharesOfCommonStockInConnectionWithMerger`	$3.69M	USD	3 Qtrs
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConvertibleNotesForSharesOfCommonStockInConnectionWithMerger`	$3.69M	USD	3 Qtrs
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConvertibleNotesForSharesOfCommonStockInConnectionWithMerger`	-	USD	3 Qtrs
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConvertibleNotesForSharesOfCommonStockInConnectionWithMerger`	-	USD	3 Qtrs
Accrued transaction costs	`AccruedTransactionCosts`	-	USD	3 Qtrs
Accrued transaction costs	`AccruedTransactionCosts`	-	USD	3 Qtrs
Accrued transaction costs	`AccruedTransactionCosts`	$5.74M	USD	3 Qtrs
Accrued transaction costs	`AccruedTransactionCosts`	$5.74M	USD	3 Qtrs
Non-cash directors and officers insurance	`NoncashDirectorsAndOfficersInsurance`	-	USD	3 Qtrs
Non-cash directors and officers insurance	`NoncashDirectorsAndOfficersInsurance`	$1.07M	USD	3 Qtrs
Non-cash directors and officers insurance	`NoncashDirectorsAndOfficersInsurance`	$1.07M	USD	3 Qtrs
Non-cash directors and officers insurance	`NoncashDirectorsAndOfficersInsurance`	-	USD	3 Qtrs
Reclassification of deferred offering costs to reduction of additional paid-in capital	`ReclassificationOfDeferredOfferingCostsToReductionOfAdditionalPaidinCapital`	$1.53M	USD	3 Qtrs
Reclassification of deferred offering costs to reduction of additional paid-in capital	`ReclassificationOfDeferredOfferingCostsToReductionOfAdditionalPaidinCapital`	$1.53M	USD	3 Qtrs
Net Liabilities assumed in the Merger	`NetLiabilitiesAssumedInMerger`	-	USD	3 Qtrs
Net Liabilities assumed in the Merger	`NetLiabilitiesAssumedInMerger`	-	USD	3 Qtrs
Net Liabilities assumed in the Merger	`NetLiabilitiesAssumedInMerger`	$6.12M	USD	3 Qtrs
Net Liabilities assumed in the Merger	`NetLiabilitiesAssumedInMerger`	$6.12M	USD	3 Qtrs
Initial value of warrant liabilities issued in connection with PIPE Financing and Closing of the Merger	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	-	USD	3 Qtrs
Initial value of warrant liabilities issued in connection with PIPE Financing and Closing of the Merger	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	$223.00K	USD	3 Qtrs
Initial value of warrant liabilities issued in connection with PIPE Financing and Closing of the Merger	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	-	USD	3 Qtrs
Initial value of warrant liabilities issued in connection with PIPE Financing and Closing of the Merger	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	$223.00K	USD	3 Qtrs

Stockholders Equity 92 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-9.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$-9.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$-14.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$-14.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Issuance of Common Stock for note payable	`StockIssuedDuringPeriodValueIssuanceOfCommonStockForNotePayable`	$996.00K	USD	3 Qtrs
Issuance of Common Stock for note payable	`StockIssuedDuringPeriodValueIssuanceOfCommonStockForNotePayable`	$996.00K	USD	3 Qtrs
Issuance of Common Stock for note payable	`StockIssuedDuringPeriodValueIssuanceOfCommonStockForNotePayable`	$996.00K	USD	1 Quarter
Issuance of Common Stock for note payable	`StockIssuedDuringPeriodValueIssuanceOfCommonStockForNotePayable`	$996.00K	USD	1 Quarter
Issuance of Common Stock for licensing right	`StockIssuedDuringPeriodValueNewIssues`	$1.57M	USD	3 Qtrs
Issuance of Common Stock for licensing right	`StockIssuedDuringPeriodValueNewIssues`	$1.57M	USD	3 Qtrs
Issuance of Common Stock for licensing right	`StockIssuedDuringPeriodValueNewIssues`	$1.57M	USD	1 Quarter
Issuance of Common Stock for licensing right	`StockIssuedDuringPeriodValueNewIssues`	$1.57M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.27M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.27M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$356.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$356.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-140.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$610.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$610.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-140.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-116.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-36.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-36.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-116.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.40M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-15.40M	USD	3 Qtrs
Issuance of Common Stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$150.00K	USD	3 Qtrs
Issuance of Common Stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$150.00K	USD	3 Qtrs
Issuance of Common Stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueOther`	-	USD	3 Qtrs
Issuance of Common Stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueOther`	-	USD	3 Qtrs
Issuance of Warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.89M	USD	3 Qtrs
Issuance of Warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.89M	USD	3 Qtrs
Reclassification of additional paid-in-capital	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	1 Quarter
Reclassification of additional paid-in-capital	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	1 Quarter
Reclassification of additional paid-in-capital	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	3 Qtrs
Reclassification of additional paid-in-capital	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 3)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.69M	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 3)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.69M	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 3)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.69M	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 3)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.69M	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	373,570.00	shares	Point-in-time
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	373,570.00	shares	Point-in-time
Merger, net of redemptions (Note 3)	`StockIssuedDuringPeriodValueAcquisitions`	$15.09M	USD	3 Qtrs
Merger, net of redemptions (Note 3)	`StockIssuedDuringPeriodValueAcquisitions`	$15.09M	USD	3 Qtrs
Merger, net of redemptions (Note 3)	`StockIssuedDuringPeriodValueAcquisitions`	$15.09M	USD	1 Quarter
Merger, net of redemptions (Note 3)	`StockIssuedDuringPeriodValueAcquisitions`	$15.09M	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 3)	`StockIssuedDuringPeriodValueNewIssuesInConnectionWithPipeFinancing`	$19.78M	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 3)	`StockIssuedDuringPeriodValueNewIssuesInConnectionWithPipeFinancing`	$19.78M	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 3)	`StockIssuedDuringPeriodValueNewIssuesInConnectionWithPipeFinancing`	$19.78M	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 3)	`StockIssuedDuringPeriodValueNewIssuesInConnectionWithPipeFinancing`	$19.78M	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC	`StockIssuedDuringPeriodValueNewIssueOne`	$151.00K	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC	`StockIssuedDuringPeriodValueNewIssueOne`	$151.00K	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC	`StockIssuedDuringPeriodValueNewIssueOne`	$151.00K	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC	`StockIssuedDuringPeriodValueNewIssueOne`	$151.00K	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 3)	`StockIssuedDuringPeriodValueIssuedForServicesOne`	-	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 3)	`StockIssuedDuringPeriodValueIssuedForServicesOne`	-	USD	3 Qtrs
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 3)	`StockIssuedDuringPeriodValueIssuedForServicesOne`	-	USD	1 Quarter
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 3)	`StockIssuedDuringPeriodValueIssuedForServicesOne`	-	USD	1 Quarter
Reduction of excise tax liability associated with the Merger (Note 3)	`AdjustmentsToAdditionalPaidInCapitalReductionOfExciseTaxLiabilityAssociatedWithMerger`	$1.14M	USD	3 Qtrs
Reduction of excise tax liability associated with the Merger (Note 3)	`AdjustmentsToAdditionalPaidInCapitalReductionOfExciseTaxLiabilityAssociatedWithMerger`	$1.14M	USD	3 Qtrs
Reduction of excise tax liability associated with the Merger (Note 3)	`AdjustmentsToAdditionalPaidInCapitalReductionOfExciseTaxLiabilityAssociatedWithMerger`	$1.14M	USD	1 Quarter
Reduction of excise tax liability associated with the Merger (Note 3)	`AdjustmentsToAdditionalPaidInCapitalReductionOfExciseTaxLiabilityAssociatedWithMerger`	$1.14M	USD	1 Quarter
Capital contribution - related party	`AdjustmentsToAdditionalPaidInCapitalContributionRelatedParty`	$150.00K	USD	1 Quarter
Capital contribution - related party	`AdjustmentsToAdditionalPaidInCapitalContributionRelatedParty`	$150.00K	USD	1 Quarter
Capital contribution - related party	`AdjustmentsToAdditionalPaidInCapitalContributionRelatedParty`	$150.00K	USD	3 Qtrs
Capital contribution - related party	`AdjustmentsToAdditionalPaidInCapitalContributionRelatedParty`	$150.00K	USD	3 Qtrs
Balance	`StockholdersEquity`	$-14.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$-14.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$-9.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-9.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.